Cambridge Investment Research Advisors
AXGN icon

Cambridge Investment Research Advisors’s Axogen AXGN Stock Holding History

Cambridge Investment Research Advisors’s Portfolio AXGN Stock Details AXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$584K Buy
12,648
+1,856
+17% +$74.8K ﹤0.01% 2816
2026
Q1 		$358K Buy
10,792
+958
+10% +$31.1K ﹤0.01% 3120
2025
Q4 		$322K Buy
+9,834
New +$242K ﹤0.01% 3129

Other funds holding AXGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Polar Capital Holdings
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Cambridge Investment Research Advisors's AXGN Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Axogen (AXGN) stake by 17% in Q2 2026, buying an estimated $74.8K and bringing the position to 12,648 shares worth $584K. The position accounts for ﹤0.01% of the portfolio, ranked #2816.

Cambridge Investment Research Advisors first reported a position in AXGN in Q4 2025 and has held it in 3 quarters since. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Cambridge Investment Research Advisors held 12,648 shares of Axogen worth $584K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 1,856 Axogen shares in Q2 2026, an estimated $74.8K.
  • Axogen made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2816 holding.
  • Cambridge Investment Research Advisors first reported a position in Axogen in Q4 2025 and has held it in 3 quarters since.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.